Mode
Text Size
Log in / Sign up
N/A Completed N=44 Randomized Quadruple-blind Treatment

Cognitive Training and tDCS for Children With FASD

Source: ClinicalTrials.gov NCT03361293 ↗
Enrolled (actual)
44
Serious AEs
0.0%
Results posted
Feb 2021
Primary outcomePrimary: BrainHQ Learning Rate — 867.6; 861.7 milliseconds

Summary

This is a randomized placebo-controlled trial of cognitive training with transcranial direct current stimulation (tDCS) for children and adolescents (ages 10 - 16 years) with prenatal alcohol exposure (PAE).

Outcome Measures

OutcomeResultp-value
PRIMARY
BrainHQ Learning Rate
867.6; 861.7
SECONDARY
Change in D-KEFS Verbal Fluency - Letter
-0.11; -0.05
SECONDARY
Change in D-KEFS Verbal Fluency - Category
-3.68; -3.42
SECONDARY
Change in D-KEFS Trail-making - Numbers
1.11; 1.37
SECONDARY
Change in D-KEFS Trail-making - Letters
1.05; -2.95
SECONDARY
Change in D-KEFS Trail-making - Combined
-1.16; -2.05
SECONDARY
Delis Rating of Executive Functioning (D-REF)
70.1; 73.2
SECONDARY
Change in Flanker Inhibitory Control and Attention Task
2.05; 3.52

Eligibility Criteria

Inclusion Criteria

  • Documented heavy prenatal alcohol exposure (self-report, social service records, or adoption records) and meeting criteria for an associated FASD diagnosis (FAS, partial FAS, or ARND).
  • An available parent or legal guardian capable of giving informed consent

Exclusion Criteria

  • Substance abuse in the participant
  • Neurological condition or other developmental disorder
  • Serious psychiatric disorder known to affect brain functioning and cognitive performance
  • Birthweight < 1500 grams
  • MRI contraindication
  • tDCS contraindication
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03361293). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search